Immediate Impact
3 standout
Citing Papers
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
2023 Standout
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2023 Standout
Works of Sarah Chisolm being referenced
Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah Chisolm | 146 | 84 | 14 | 88 | 13 | 238 | |
| E. K. Derrick | 84 | 54 | 3 | 62 | 13 | 237 | |
| Fred Ghali | 118 | 75 | 16 | 66 | 19 | 246 | |
| Miriam Sánchez | 105 | 58 | 11 | 24 | 16 | 287 | |
| Yavuz Harmanyeri | 75 | 43 | 12 | 80 | 17 | 245 | |
| P Mortureux | 113 | 28 | 6 | 87 | 10 | 241 | |
| M.-L. Bouyssou-Gauthier | 61 | 106 | 6 | 116 | 12 | 266 | |
| John Brenan | 84 | 68 | 11 | 65 | 14 | 264 | |
| J. Wendling | 91 | 77 | 17 | 37 | 12 | 261 | |
| J Ring | 224 | 32 | 9 | 76 | 13 | 279 | |
| Robert Tremaine | 94 | 74 | 5 | 79 | 12 | 296 |
All Works
Login with ORCID to disown or claim papers
Loading papers...